Peripheral neuropathy in patients on long-term triazole antifungal therapy

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2136-2139

  Baxter, Caroline G ^a,b   Marshall, Andrew ^a,b   Roberts, Mark ^a   Felton, Timothy W ^a,b   Denning, David W ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aspergillosis; Itraconazole; Nerve conduction studies; Posaconazole; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ABNORMAL SENSATION; ADULT; AGED; ANTIFUNGAL THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLOSIS; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INCIDENCE; LEG; LONG TERM CARE; MALE; MONONEUROPATHY; MOTOR NEUROPATHY; MUSCLE WEAKNESS; PARESTHESIA; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; TINGLING SENSATION; UNITED KINGDOM;

ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; ITRACONAZOLE; LONG-TERM CARE; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PYRIMIDINES; RETROSPECTIVE STUDIES; TRIAZOLES; YOUNG ADULT;

EID: 80051700825     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr233     Document Type: Article

References (10)

1. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
2. enning DW, Riniotis K, Dobrashian R et al. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37 Suppl 3: S265-80.
3. Denning DW, O'Driscoll BR, Hogaboam CM et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-26.
4. Stevens DA, Schwartz HJ, Lee JY et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756-62.
5. Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009; 179: 11-8.
6. Stevens DA, Moss RB, Kurup VP et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 Suppl 3: S225-64.
7. Tucker RM, Haq Y, Denning DW et al. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 1990; 26: 561-6.
8. Bradley WG, Karlsson IJ, Rassol CG. Metronidazole neuropathy. Br Med J 1977; 2: 610-1.
9. Chen H, Chan DC. Critical dependence of neurons on mitochondrial dynamics. Curr Opin Cell Biol 2006; 18: 453-9.
10. Cartwright ME, Petruska J, Arezzo J et al. Phospholipidosis in neurons caused by posaconazole, without evidence for functional neurologic effects. Toxicol Pathol 2009; 37: 902-10.